Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-26 @ 11:08 AM
Ignite Modification Date: 2025-12-26 @ 11:08 AM
NCT ID: NCT02032212
Description: None
Frequency Threshold: 0
Time Frame: 5 days
Study: NCT02032212
Study Brief: A Bioavailability Study of Nicotine Delivered by an Electronic Vapour Product
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
EVP Unflavoured Unflavoured e-vapour product None None 0 12 1 12 View
EVP Flavoured Flavoured e-vapour product None None 0 12 3 12 View
Nicotine Inhalator Nicotine inhalator 15mg None None 0 12 3 12 View
Conventional Cigarette Conventional cigarette (commercially available) None None 0 12 0 12 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Cough SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (16.1) View
Throat irritation SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (16.1) View
Glossodynia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (16.1) View
Nasopharyngitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (16.1) View